Skip to content
Agenus
  • About Us
    • Overview
    • Team
    • Our History
  • Pipeline
  • Capabilities
    • VISION
    • Manufacturing
    • Clinical
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock
    • SEC Filings
    • Analyst Coverage
    • Governance
    • Investor Resources
  • Join us
Menu
  • About Us
    • Overview
    • Team
    • Our History
  • Pipeline
  • Capabilities
    • VISION
    • Manufacturing
    • Clinical
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock
    • SEC Filings
    • Analyst Coverage
    • Governance
    • Investor Resources
  • Join us

NLM001 + Zalifrelimab

Agenus Inc.
3 Forbes Road
Lexington, MA 02421-7305
T: +1 781.674.4400 | F: +1 781.674.4200

© 2023 Agenus Inc. All rights reserved.
  • Privacy policy
  • Terms and conditions of use
  • Cookie Policy
  • Opt-out preferences
Menu
  • Privacy policy
  • Terms and conditions of use
  • Cookie Policy
  • Opt-out preferences
Menu
  • Overview
  • Pipeline
  • Capabilities
    • VISION
    • Manufacturing
    • Clinical
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock
    • SEC Filings
    • Analyst Coverage
    • Governance
    • Investor Resources
  • Join us
  • Contact us
Linkedin-in Twitter